Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Epilepsy is common in early childhood. In this age group it is associated with high rates of therapy-resistance, and with cognitive, motor, and behavioural comorbidity. A large number of genes, with wide ranging functions, are implicated in its aetiology, especially in those with therapy-resistant seizures. Identifying the more common single-gene epilepsies will aid in targeting resources, the prioritization of diagnostic testing and development of precision therapy. Previous studies of genetic testing in epilepsy have not been prospective and population-based. Therefore, the population-incidence of common genetic epilepsies remains unknown. The objective of this study was to describe the incidence and phenotypic spectrum of the most common single-gene epilepsies in young children, and to calculate what proportion are amenable to precision therapy. This was a prospective national epidemiological cohort study. All children presenting with epilepsy before 36 months of age were eligible. Children presenting with recurrent prolonged (>10 min) febrile seizures; febrile or afebrile status epilepticus (>30 min); or with clusters of two or more febrile or afebrile seizures within a 24-h period were also eligible. Participants were recruited from all 20 regional paediatric departments and four tertiary children’s hospitals in Scotland over a 3-year period. DNA samples were tested on a custom-designed 104-gene epilepsy panel. Detailed clinical information was systematically gathered at initial presentation and during follow-up. Clinical and genetic data were reviewed by a multidisciplinary team of clinicians and genetic scientists. The pathogenic significance of the genetic variants was assessed in accordance with the guidelines of UK Association of Clinical Genetic Science (ACGS). Of the 343 patients who met inclusion criteria, 333 completed genetic testing, and 80/333 (24%) had a diagnostic genetic finding. The overall estimated annual incidence of single-gene epilepsies in this well-defined population was 1 per 2120 live births (47.2/100 000; 95% confidence interval 36.9–57.5). PRRT2 was the most common single-gene epilepsy with an incidence of 1 per 9970 live births (10.0/100 000; 95% confidence interval 5.26–14.8) followed by SCN1A: 1 per 12 200 (8.26/100 000; 95% confidence interval 3.93–12.6); KCNQ2: 1 per 17 000 (5.89/100 000; 95% confidence interval 2.24–9.56) and SLC2A1: 1 per 24 300 (4.13/100 000; 95% confidence interval 1.07–7.19). Presentation before the age of 6 months, and presentation with afebrile focal seizures were significantly associated with genetic diagnosis. Single-gene disorders accounted for a quarter of the seizure disorders in this cohort. Genetic testing is recommended to identify children who may benefit from precision treatment and should be mainstream practice in early childhood onset epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss-of-function (LOF) missense or truncating variants cause Dravet syndrome, the prototypic DEE 13,27 , and also the non-DEE syndrome of Genetic Epilepsy with Febrile Seizures Plus (GEFS+) 28 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The incidence of syndromes associated with de novo genetic variants is likely to be similar around the world 13 ; whereas, recessive causes occur more frequently in populations with high rates of consanguinity 14 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., et al. (2017) · Epilepsia · doi:10.1111/epi.13709 · Cited by 5,054 · cited 1×
“The concept of the ‘developmental and epileptic encephalopathy’ (DEE) recognizes that in children presenting with early-onset epilepsy, neurodevelopmental comorbidity may be attributable to both the underlying cause and to the detrimental effects of uncontrolled epileptic activity (Scheffer et al., 2017).”
Self-citationIncidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984
Hauser, W. A., Annegers, J. F., & Kurland, L. T. (1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb02586.x · Cited by 2,073
Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies
Fiest, K. M., Sauro, K. M., Wiebe, S., Patten, S. B., Kwon, C.-S., Dykeman, J., Pringsheim, T., Lorenzetti, D. L., & Jetté, N. (2017) · Neurology · doi:10.1212/wnl.0000000000003509 · Cited by 1,902
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711
Estimation of the burden of active and life-time epilepsy: a meta-analytic approach
Ngugi, A. K., Bottomley, C., Kleinschmidt, I., Sander, J. W., & Newton, C. R. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02481.x · Cited by 1,447 · cited 1×
“, 2017) and that 50–65 million individuals are affected worldwide (Ngugi et al., 2010; Fiest et al., 2017).”
A Potassium Channel Mutation in Neonatal Human Epilepsy
Biervert, C., Schroeder, B. C., Kubisch, C., Berkovic, S. F., Propping, P., Jentsch, T. J., & Steinlein, O. K. (1998) · Science · doi:10.1126/science.279.5349.403 · Cited by 1,073 · cited 1×
“The literature describes two distinct phenotypes associated with KCNQ2 variants: a self-limited familial neonatal seizure phenotype (Biervert et al., 1998; Singh et al., 2003) and a severe neonatal-onset developmental and epileptic encephalopathy (Weckhuysen et al.”
Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
Devinsky, O., Patel, A. D., Cross, J. H., Villanueva, V., Wirrell, E. C., Privitera, M., Greenwood, S. M., Roberts, C., Checketts, D., VanLandingham, K. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714631 · Cited by 1,015 · cited 2×
“Cannabidiol also has efficacy in Lennox Gastaut syndrome (French et al., 2017; Devinsky et al., 2018), an epilepsy with varied aetiologies.”
Self-citationDevinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., Katz, R., Di Marzo, V., Jutras‐Aswad, D., Notcutt, W. G., et al. (2014) · Epilepsia · doi:10.1111/epi.12631 · Cited by 1,000 · cited 1×
“In Dravet syndrome cannabidiol demonstrates efficacy (Devinsky et al. , 2017); however, there is no biological reason why cannabidiol should be specifically effective in this condition because it does not appear to act on sodium channels or GABA receptors (Devinsky et al. , 2014).”
Research works printed but not linked: 1
- The Broad Institute: Cambridge MA 2018. gnomAD Browser. http://gnomad.broadinstitute.org/(April 2018, date last accessed).
Cited by
Items 301–400 of 456
Haploinsufficiency underlies the neurodevelopmental consequences of SLC6A1 /GAT-1 variantsPreprint
Silva, D. B., Trinidad, M. I., Ljungdahl, A., Revalde, J. L., Berguig, G. Y., Wallace, W., Patrick, C. S., Bomba, L., Arkin, M. R., Dong, S., et al. (2022) · medRxiv · doi:10.1101/2022.03.09.22271804 · Cited by 3
Editorial: Genetically determined epilepsies: Perspectives in the era of precision medicine
Mastrangelo, M., Salpietro, V., & Sullivan, J. E. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1036846 · Cited by 3
CONVEX: Consensus Variant Pipeline for Exome AnalysisPreprint
Raju, R. M., Singh, U. P., & Suravajhala, P. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.07.561328 · Cited by 3
Rapid modeling of an ultra-rare epilepsy variant in wild-type mice by in utero prime editingPreprint
Robertson, C. D., Davis, P. W., Richardson, R. R., Iffland, P. H., Vieira, D. C. O., Steyert, M. R., McKeon, P. N., Romanowski, A. J., Crutcher, G. W., Jašarević, E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.06.570164 · Cited by 4
Identification of novel epilepsy genetics and development of advanced diagnostic approaches
Veerabathiran, R., & Iyshwarya, B. K. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100202 · Cited by 2
Jonsson, H., de Sena, S., Linnankivi, T., Gaily, E. K., & Stjerna, S. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110397 · Cited by 4
Boulaki, V., Efthimiopoulos, S., Moschonas, N. Κ., & Spyrou, G. M. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106888 · Cited by 3
Clements, M. E., Abath, C. B., Curcio, A. M., Douglass, L. M., Kassiri, J., Liu, L. C., Mathias, S. V., Moore‐Hill, D., Nalluri, D., Nath, A. R., et al. (2025) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2025.11.002 · Cited by 3
Bidwell, J. S., Vanoye, C. G., Desai, R. R., Berg, A. T., & George, A. L. (2025) · Epilepsia Open · doi:10.1002/epi4.70192 · Cited by 2
Cortesi, P. A., Fornari, C., Boncristiano, A., Facchetti, R., Balestrini, S., Doccini, V., Specchio, N., Pietrafusa, N., Trivisano, M., Darra, F., et al. (2025) · Epilepsia Open · doi:10.1002/epi4.70200 · Cited by 4
Heterogeneity of monogenic epilepsy in loci, phenotypes, and treatment approaches
Saad, A. K., & Akawi, N. A. (2026) · Neurological Sciences · doi:10.1007/s10072-026-08936-2 · Cited by 2
Cestèle, S., Harper, A. J., Marra, S., Leroudier, N., Rusconi, R., Dhifallah, S., Horrocks, I. A., Kirkham, F. J., Morgan, I. M. R., Singh, J., et al. (2026) · Neurology Genetics · doi:10.1212/nxg.0000000000200352 · Cited by 2
Self-citationSeizures, semiology, and syndromes: A narrative review
Boßelmann, C. M. (2021) · Seizure · doi:10.1016/j.seizure.2021.09.019 · Cited by 2
Huang, T., Ma, G., Chen, M., Li, W.-F., & Shaw, S. W. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.612100 · Cited by 2
Woo, S., Nah, S., Kim, M., Kim, S., Lee, D., Lee, J. W., Moon, J. E., & Han, S. (2023) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2022.12.57505 · Cited by 2
Akiyama, L. F., & Saneto, R. P. (2023) · Pediatric Annals · doi:10.3928/19382359-20230829-01 · Cited by 3
Ma, Y., Deng, J., Fu, Z., Chen, C., Wang, X., Wang, X., Weng, J., Shen, Y., Wang, X., & Fang, F. (2023) · Epilepsy Research · doi:10.1016/j.eplepsyres.2023.107240 · Cited by 3
A novel duplication mutation of SLC2A1 gene causing glucose transporter 1 deficiency syndrome
Huang, C., Huang, Y., Pan, L., Li, L., Ling, X., Wang, C., Xiao, Q., Zhai, N., Long, Y., Mo, W., et al. (2024) · Gene · doi:10.1016/j.gene.2024.148762 · Cited by 2
Gould, A., & Amin, S. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2385937 · Cited by 3
Phenotypic and genotypic characteristics of children with PCDH19 clustering epilepsy in China
Feng, W., Wang, Z., Wang, X., Chen, S., Chen, X., Chen, C., Deng, J., Zhuo, X. W., & Wang, J. (2024) · Seizure · doi:10.1016/j.seizure.2024.07.023 · Cited by 2
Smal, N., Millevert, C., Wachter, M. D., Vriendt, E. D., Eddafir, Z., Schoonjans, A., Bayat, A., Møller, R. S., Mei, D., Balestrini, S., et al. (2025) · Epilepsia · doi:10.1111/epi.18279 · Cited by 2
Vera-López, K. J., Zenteno, M. A., Dávila-Del-Carpio, G., & Nieto-Montesinos, R. (2025) · Neurology International · doi:10.3390/neurolint17030038 · Cited by 3
Pediatric paroxysmal movement disorders - A clinical epidemiological study in an Irish cohort
Harvey, S., Allen, N. M., Byrne, S., Lynch, B. J., McSweeney, N., Neville, S., O’Mahony, O., O’Regan, M., O’Rourke, D., Reade, E., et al. (2025) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2025.03.006 · Cited by 2
Self-citationMartín-Carrascosa, M. D. C., Palacios-Martínez, C., & Galindo, M. I. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1582684 · Cited by 3
Sasaki, E., Millington, P., Sazonova, T., Hanington, L., Parrish, A., Baños-Piñero, B., Lord, H., Taylor, J., Jeeneea, R., Sherlaw‐Sturrock, C., et al. (2025) · European Journal of Human Genetics · doi:10.1038/s41431-025-01870-5 · Cited by 2
Abnormalities in the functional activity of neural networks in a human iPSC model of Dravet syndrome
Mzezewa, R., Hyvärinen, T., Kulta, O., Vinogradov, A., Pesu, E., Isosaari, L., Vuolanto, V., Kapucu, F. E., Schuster, J., Dahl, N., et al. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.104958 · Cited by 4
A potential new treatment for CDKL5 deficiency disorder
Gill, D. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00127-2 · Cited by 2
Sharkov, A. A., Sparber, P. A., Stepanova, A. A., Pyankov, D., Korostelev, S. A., & Skoblov, M. Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.888481 · Cited by 3
Yoshimura, Y., Morii, A., Fujino, Y., Nagase, M., Kitano, A., Ueno, S., Takeuchi, K., Yamashita, R., & Inazu, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012281 · Cited by 2
Percy, A. K., Neul, J. L., Peters, S. U., Brockmann, K., Marsh, E. D., & Benke, T. A. (2023) · Translational Science of Rare Diseases · doi:10.3233/trd-220055 · Cited by 3
Growth patterns in individuals with CDKL5 deficiency disorder
Wong, K., Davies, G., Leonard, H., Downs, J. A., Junaid, M. A., & Amin, S. (2023) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.15777 · Cited by 2
Genetic testing in adult epilepsy patients: A call to action for clinicians
Rubboli, G., Møller, R. S., & Johannesen, K. M. (2020) · Epilepsia · doi:10.1111/epi.16639 · Cited by 2
Boßelmann, C. M., Hedrich, U. B. S., Lerche, H., & Pfeifer, N. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.29.510111 · Cited by 2
Mueller, K., Shine, M. G., Lee, J. W., Lee, S., & Malone, K. E. (2024) · Research Square · doi:10.21203/rs.3.rs-4949811/v1 · Cited by 2
The natural history of CDKL5 deficiency disorder into adulthoodPreprint
Aledo‐Serrano, Á., Lewis‐Smith, D., Leonard, H., Bayat, A., Junaid, M. A., Hagebeuk, E. E. O., Fenger, C., Laze, J., Rossi, A., Trivisano, M., et al. (2025) · medRxiv · doi:10.1101/2025.01.12.24318239 · Cited by 2
Tang, M., Teng, S., Peng, Y., Kim, A. Y., Canoll, P., Bruce, J. N., Faust, P. L., Adhikari, K., Vivo, D. C. D., & Monani, U. R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.26.644647 · Cited by 2
Epilepsietypische Hirnaktivität
Wenzel, M., Rácz, Á., & Surges, R. (2023) · Springer eBooks · doi:10.1007/978-3-662-63267-3_7 · Cited by 1
Torres, S. S. O., Sanchez, C. M., & Steele, G. S. (2024) · Therapeutic Advances in Rare Disease · doi:10.1177/26330040241265421 · Cited by 2
The long odyssey for the DEE‐CDKL5 diagnosis: A call for action
Valente, K. D. R., de Melo, F. E. B., Marin, R., Vega, G., Neves‐Borg, A., Spagnol, B., Montenegro, M. A., & Vincentiis, S. (2024) · Epilepsia Open · doi:10.1002/epi4.13031 · Cited by 1
Epilepsy genetics in the paediatric population of the Eastern Anatolia region of Turkey
Yaralı, O., Öğütlü, Ö. B. G., Saritaş, S., Güler, M. C., Keskin, F., & Türkyılmaz, A. (2024) · Journal of Neurogenetics · doi:10.1080/01677063.2024.2424777 · Cited by 1
Mottolese, N., Loi, M., Trazzi, S., Tassinari, M., Uguagliati, B., Candini, G., Iqbal, K., Medici, G., & Ciani, E. (2024) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-024-09583-4 · Cited by 1
A new loss-of-function variant in SCN1A is associated with early-onset complex febrile seizures
Christophersen, I. E., Waele, J. J. D., Aaberg, K. M., Henning, S., Backe, P. H., Kulseth, M. A., Mero, I., & Bosmans, F. (2025) · Seizure · doi:10.1016/j.seizure.2025.08.010 · Cited by 1
Brain Volumetric Differences in Pediatric Epilepsy: A Focus on Genetic Etiology
Park, S., Lim, Y., Park, K. M., & Hur, Y. J. (2025) · Annals of Child Neurology · doi:10.26815/acn.2025.01004 · Cited by 2
Jacoby, P. A., Marsh, E. D., Demarest, S., Saldaris, J. M., Leonard, H., Olson, H. E., Saby, J. N., Pestana‐Knight, E., Rajaraman, R. R., Price, D., et al. (2025) · Brain and Behavior · doi:10.1002/brb3.71061 · Cited by 1
Fieberkrämpfe in der Pädiatrie
Steinbrücker, K., & Koch, J. (2025) · Clinical Epileptology · doi:10.1007/s10309-025-00801-0 · Cited by 1
D’ardhuy, X. L., Partners, C., Cimms, T., Lindsten, K., Rizzo, M., Skrinar, A. M., Wecker, P. S., Mingorance, A., & Devinsky, O. (2026) · Epilepsia · doi:10.1002/epi.70095 · Cited by 2
Chałupczyńska, B., Ciara, E., Halat-Wolska, P., Pollak, A., Stawiński, P., Jurkiewicz, D., Piekutowska‐Abramczuk, D., Gawlik, M., Pietrasik, J., Cieślikowska, A., et al. (2026) · Genes · doi:10.3390/genes17020133 · Cited by 1
Thompson, E. C., Cooper, E. C., & Miller, B. R. (2026) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2026.2623490 · Cited by 2
Perulli, M., de Gioia, A., Ruggiero, F., Ascione, F., Porto, C., Musto, E., Massaroni, V., Picilli, M., Gambardella, M. L., Quintiliani, M., et al. (2026) · Epilepsia Open · doi:10.1002/epi4.70213 · Cited by 1
Zhao, F., Hu, W., Zhang, W., Lu, Y., Li, J., & Zhang, H. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1701141 · Cited by 1
Dominicis, A. D., Mercier, M., Pavia, G. C., Piscitello, L. M., Cappelletti, S., Filosomi, C., Correale, C., Calabrese, C., Palma, L. D., Novelli, A., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000214761 · Cited by 1
Jadhav, T., Bouffler, S. E., Innes, E. A., Fahey, M. C., Hunter, M., Kothur, K., Lunke, S., Lynch, M., Macdonald‐Laurs, E., Palmer, E. E., et al. (2026) · Epilepsia Open · doi:10.1002/epi4.70266 · Cited by 1
Latzer, I. T., Hong, W., Zhang, B., Lucash, J., Zhang, X. X., Olson, H. E., & Pestana‐Knight, E. (2026) · Neurology · doi:10.1212/wnl.0000000000218500 · Cited by 1
Keenan, N. F., Stanley, J., Stairmand, J., Ali, S. S., Andersen, E., Davis, S. L., & Sadleir, L. G. (2026) · Neurology · doi:10.1212/wnl.0000000000218688 · Cited by 1
Murachueva, F. A., & Гейбатовна, Г. Л. (2020) · Medical alphabet · doi:10.33667/2078-5631-2020-1-31-35 · Cited by 1
Putra, S. H. (2023) · Jurnal Indonesia Sosial Teknologi · doi:10.59141/jist.v4i4.598 · Cited by 1
Novel copy number variations and phenotypes of infantile epileptic spasms syndrome
Cheng, M., Bai, L., Yang, Y., Liu, W., Niu, X., Chen, Y., Tan, Q., Yang, X., Wu, Q., Zhao, H., et al. (2024) · Clinical Genetics · doi:10.1111/cge.14520 · Cited by 1
Игоревна, Ш. Н., Михайлов, В. А., & Дмитриевич, Р. Г. (2024) · Epilepsy and Paroxysmal Conditions · doi:10.17749/2077-8333/epi.par.con.2024.182 · Cited by 1
Fariyike, O. A., Narayan, N., Liu, H. Y., Sanchez, D. R., & Phillips, H. W. (2025) · Frontiers in Surgery · doi:10.3389/fsurg.2025.1568939 · Cited by 1
Amin, S., Partridge, C., Leonard, H., Downs, J. A., Allvin, H., Ficara, V., Pain, É., & Korolainen, M. A. (2025) · JMIR Formative Research · doi:10.2196/72489 · Cited by 1
Potassium Channel Mutations in Epilepsy
Palmer, E. E. (2020) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190669164.013.13 · Cited by 1
Genetics in the epilepsies – A broadening concept
Cross, J. H. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2020.01.009 · Cited by 1
Genetic epilepsies and the Kv super-family
Salpietro, V., & Houlden, H. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2020.01.013 · Cited by 1
Epilepsy gene panel yield and impact on outcomes for adults with unexplained seizures
Borlot, F., & Andrade, D. M. (2020) · Epilepsia · doi:10.1111/epi.16606 · Cited by 1
Plural molecular and cellular mechanisms of pore domain KCNQ2 encephalopathyPreprint
Abreo, T. J., Thompson, E. C., Madabushi, A., Soh, H., Varghese, N., Vanoye, C. G., Springer, K., Park, K., Johnson, J., Sims, S., et al. (2024) · eLife · doi:10.7554/elife.91204.2 · Cited by 2
CDKL5’s role in microtubule-based transport and cognitive functionPreprint
Lopes, A. T., Janiv, O., Claxton, S., & Ultanir, S. K. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.28.610038 · Cited by 1
Coupling Between Functionality and Trafficking to the Axon Initial Segment in KCNQ2/3 K + ChannelsPreprint
Yoshioka, D., & Okamura, Y. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.17.617761 · Cited by 1
Ochoa‐Urrea, M., Butler, E. A., Bruenger, T., Leu, C., Boßelmann, C. M., Najm, I., Lhatoo, S. D., & Lal, D. (2024) · medRxiv · doi:10.1101/2024.12.25.24319647 · Cited by 1
Difficult to treat epilepsy: Could it be Dravet?
Williamson, N. (2019) · British Journal of School Nursing · doi:10.12968/bjsn.2019.14.7.325
Seizures cluster around genetics
Striano, P. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2020.01.011
Epilepsy kinase CDKL5 is a DNA damage sensor which controls transcriptional activity at DNA breaksPreprint
Khanam, T., Munoz, I. M., Weiland, F., Carroll, T. D., Borsos, B. N., Pantazi, V., Slean, M. M., Novak, M. J., Toth, R. L., Appleton, P. L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.10.419747
Self-citationFenfluramine als nieuwe behandeloptie bij het syndroom van Dravet
Lagae, L. G. (2020) · Epilepsie periodiek voor professionals · doi:10.54160/epilepsie.11207
Febrile seizures, not so benign
Vatkar, A., Amit, S., Wadhawan, P., & Sharif, M. (2022) · International Journal of Paediatrics and Geriatrics · doi:10.33545/26643685.2021.v4.i2a.150
Precision in child neurology: Networks, systems, and technology
Zuberi, S. M. (2022) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.15222 · Cited by 1
Self-citationA hyperthermic seizure unleashes a surge of spreading depolarizations in Scn1a deficient micePreprint
Aiba, I., Ning, Y. Y., & Noebels, J. L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.10.511466
Deficiencia del transportador de glucosa tipo 1: aspectos clínicos, diagnóstico y terapéutica
Veneru, G., Loo, M., Armen, M., Alons, C., & Caraball, R. (2022) · Archivos Argentinos de Pediatria · doi:10.5546/aap.2022-02677 · Cited by 15
multidisciplinaire polikliniek voor kinderen met het Dravetsyndroom
Verhoeven, J. S., & Teunissen, M. W. A. (2022) · Epilepsie periodiek voor professionals · doi:10.54160/epilepsie.12871
Genetische Aspekte kindlicher Epilepsiesyndrome
Syrbe, S. (2022) · Kinder- und Jugendmedizin · doi:10.1055/a-1915-9895
Wang, S., van Hugte, E., Ciptasari, U., & Kasri, N. N. (2022) · Neuromethods · doi:10.1007/978-1-0716-2569-9_7
Boßelmann, C. M., Ivaniuk, A., John, M. S., Taylor, S. C., Krishnaswamy, G., Milinovich, A., Leu, C., Gupta, A., Pestana‐Knight, E., Najm, I., et al. (2023) · medRxiv · doi:10.1101/2023.05.27.23290634
Microcephaly, Dystonia, and Periodic Ataxia in a 10-year-old Boy
Little, J. N., Intagliata, V., & Garris, J. F. (2023) · Pediatrics in Review · doi:10.1542/pir.2021-005322
Bukreeva, E. A., Леонидович, С. П., Krapivkin, A. I., Sergeenko, E. Y., & Laisheva, O. A. (2023) · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) · doi:10.21508/1027-4065-2023-68-3-77-82
Vitamin D and Inborn Errors of Metabolism
Silva, M. F. S., Leal-Witt, M. J., Hamilton, V., V, & Cornejo, V. (2023) · Biochemistry · doi:10.5772/intechopen.112027 · Cited by 2
Retracted: Clinical and genetic evaluations of rare childhood epilepsies in Turkey's national cohort
Ünalp, A., Güzin, Y., Ünay, B., Tosun, A. F., Çavuşoğlu, D., Tekin, H. G., Kurul, S. H., Arhan, E., Edizer, S., Öztürk, G., et al. (2023) · Epileptic Disorders · doi:10.1002/epd2.20150
RetractedExperimental Models for the Study of Drug-Resistant Epilepsy
Fuentes-Mejía, M., Nuñez-Lumbreras, A., Martínez-Aguirre, C., & Rocha, L. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-36526-3_3
Palacios‐Ceña, D., Güeita‐Rodríguez, J., Gil‐Nagel, A., Jiménez‐Antona, C., García‐Bravo, C., Velarde‐García, J. F., Cuenca‐Zaldívar, J. N., & Aledo‐Serrano, Á. (2023) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.15755
Benchmarking whole exome sequencing pipeline for predicting pathogenic variants of significancePreprint
Raju, R. M., Singh, U. P., & Suravajhala, P. (2023) · Research Square · doi:10.21203/rs.3.rs-3613176/v1 · Cited by 1
De IBIS studie: motorische ontwikkeling als voorspeller van Dravetsyndroom
Heineman, K. R., Brilstra, E. H., & de Berg, L. V. (2023) · Epilepsie periodiek voor professionals · doi:10.54160/epilepsie.17706
Plural molecular and cellular mechanisms of pore domain KCNQ2 encephalopathyPreprint
Abreo, T. J., Thompson, E. C., Madabushi, A., Soh, H., Varghese, N., Vanoye, C. G., Springer, K., Park, K., Johnson, J., Sims, S., et al. (2024) · eLife · doi:10.7554/elife.91204.1
The impact of developmental and epileptic encephalopathies on families: A qualitative studyPreprint
Velarde‐García, J. F., Güeita‐Rodríguez, J., Jiménez‐Antona, C., García‐Bravo, C., Aledo‐Serrano, Á., Gómez-Sanchez, S. M., & Palacios‐Ceña, D. (2024) · Research Square · doi:10.21203/rs.3.rs-4196692/v1
Mattei, C., Mao, M., Byars, S., Syazwan, E. S. M., Oliva, M., Karle, T. J., Richards, K., Scheffer, I. E., Petrou, S., & Maljevic, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.09.593441
Clinical and genetic analysis of 18 patients with KCNQ2 mutations from South China
Cao, B., Peng, B., Tian, Y., Wang, X. J., Li, X., Zhu, H., Shen, H., & Chen, W. (2024) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2024.4593 · Cited by 1
Exome Sequencing of 963 Chinese Families Identifies Novel Epilepsy Candidate GenesPreprint
Ma, Y., Su, K., Zhou, M., Liu, Y., Lu, G., Wang, J., Li, C., Wang, T., Li, Y., Zhang, Q., et al. (2024) · medRxiv · doi:10.1101/2024.06.11.24308522
Exome Sequencing of 963 Chinese Families Identifies Novel Epilepsy Candidate GenesPreprint
Fan, S., Ma, Y., Su, K., Zhou, M., Liu, Y., Lu, G., Li, C., Wang, T., Li, Y., Zhang, Q., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4215666/v1
Dedeurwaerdere, S., Marra, V., & Johnson, M. R. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780197549469.003.0065 · Cited by 1
Síndrome de Dravet: caso clínico
Loja, A. G. R., Cárdenas, M. F. P., & Rivas, R. J. M. (2024) · Anatomía Digital · doi:10.33262/anatomiadigital.v7i3.3.3179
Khusiwilai, K., Rojnueangnit, K., Puttamanee, S., Mekmangkonthong, A., & Paticheep, S. (2024) · F1000Research · doi:10.12688/f1000research.147836.1 · Cited by 1
Tonic and tonic-clonic seizures in the first year of life: Insights from electrographic features
Conti, M., Mercier, M., Serino, D., Piscitello, L. M., Santarone, M. E., Vigevano, F., Specchio, N., & Fusco, L. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2024.110120
Li, Y. (2024) · Epiliepsy currents/Epilepsy currents · doi:10.1177/15357597241290322
Metadata
- Authors
- Symonds, J. D., Zuberi, S. M., Stewart, K., McLellan, A., O‘Regan, M., MacLeod, S., Jollands, A., Joss, S., Kirkpatrick, M., Brunklaus, A., Pilz, D. T., Shetty, J., Dorris, L., Abu-Arafeh, I., Andrew, J., Brink, P., Callaghan, M., Cruden, J., Diver, L. A., Findlay, C., Gardiner, S., Grattan, R., Lang, B., MacDonnell, J., McKnight, J., Morrison, C. A., Nairn, L., Slean, M. M., Stephen, E., Webb, A., Vincent, A., & Wilson, M.
- Affiliations
- Royal Hospital for Children (GB)
- Queen Elizabeth University Hospital (GB)
- Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK
- NHS Tayside (GB)
- Department of Paediatrics, Forth Valley Royal Hospital, Larbert, UK
- Wishaw General Hospital (GB)
- Victoria Hospital (GB)
- University Hospital Crosshouse (GB)
- Forth Valley Royal Hospital (GB)
- John Radcliffe Hospital (GB)
- Borders General Hospital (GB)
- Dumfries and Galloway Royal Infirmary (GB)
- Royal Alexandra Hospital (GB)
- University of Glasgow (GB)
- Royal Aberdeen Children's Hospital (GB)
- Raigmore Hospital (GB)
- Corresponding author
- Zuberi, Sameer M
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-07-13
- Volume
- 142
- Issue
- 8
- Pages
- 2303-2318
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6658850
- OpenAlex
- W2961503558
- Cited by
- 459
- References
- 81
- Citations by year
- 2026: 49 · 2025: 82 · 2024: 87 · 2023: 67 · 2022: 76 · 2021: 44 · 2020: 48 · 2019: 6
- FWCI
- 34.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, cc-by-nc)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Epilepsy Research UK
- Dravet Syndrome UK
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- childhood-onset epilepsy, genetic epilepsy, incidence, phenotypic spectrum, PRRT2, SCN1A, KCNQ2, KCNQ3, KCNA2, KCNA1, Kv1.3 potassium channel, Kv1.5, KC
- MeSH terms
- Child, Preschool, Epilepsy, Female, Humans, Infant, Infant, Newborn, Male, Phenotype, Prospective Studies, Scotland, Cohort Studies, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.